Salveen Richter
Stock Analyst at Goldman Sachs
(3.23)
# 1,096
Out of 5,017 analysts
200
Total ratings
42.11%
Success rate
4.11%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $70.59 | -7.92% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $24.14 | -25.43% | 9 | Sep 26, 2025 | |
| QURE uniQure | Maintains: Neutral | $13 → $56 | $62.02 | -9.71% | 8 | Sep 25, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $14.25 | +82.46% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $464.95 | +21.73% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $9.67 | +292.97% | 5 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $21.96 | -13.48% | 6 | Aug 7, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Sell | $15 → $17 | $20.06 | -15.25% | 9 | Aug 7, 2025 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $37 | $20.66 | +79.09% | 1 | Jun 16, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $68.29 | -31.18% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $13 | $16.61 | -21.73% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $52.45 | +98.28% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $22.93 | +78.81% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $8.20 | +9.76% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $15.50 | -35.48% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $557.73 | +44.16% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $144.69 | +36.15% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $6.27 | +187.08% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $118.21 | -18.79% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $26.74 | +90.73% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $14.98 | +167.02% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $23.76 | -49.49% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $84.73 | -17.38% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $32.02 | +137.35% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $40.90 | +29.58% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $292.41 | +19.70% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $407.37 | +37.22% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $22.47 | -77.75% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.27 | +2,350.59% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $307.97 | -26.94% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $5.65 | +289.38% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.83 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.64 | +431.91% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $5.53 | +62.75% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $5.05 | -40.59% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.35 | +38.09% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $56.35 | -23.69% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $4.42 | -54.75% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $14.75 | +577.97% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $8.69 | +6,804.49% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $93.23 | -46.37% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $36.25 | +24.14% | 1 | Mar 17, 2020 |
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $70.59
Upside: -7.92%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $24.14
Upside: -25.43%
uniQure
Sep 25, 2025
Maintains: Neutral
Price Target: $13 → $56
Current: $62.02
Upside: -9.71%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $14.25
Upside: +82.46%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $464.95
Upside: +21.73%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $9.67
Upside: +292.97%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $21.96
Upside: -13.48%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $20.06
Upside: -15.25%
Enliven Therapeutics
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $20.66
Upside: +79.09%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $68.29
Upside: -31.18%
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $16.61
Upside: -21.73%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $52.45
Upside: +98.28%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $22.93
Upside: +78.81%
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $8.20
Upside: +9.76%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $15.50
Upside: -35.48%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $557.73
Upside: +44.16%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $144.69
Upside: +36.15%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $6.27
Upside: +187.08%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $118.21
Upside: -18.79%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $26.74
Upside: +90.73%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.98
Upside: +167.02%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $23.76
Upside: -49.49%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $84.73
Upside: -17.38%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $32.02
Upside: +137.35%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $40.90
Upside: +29.58%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $292.41
Upside: +19.70%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $407.37
Upside: +37.22%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $22.47
Upside: -77.75%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.27
Upside: +2,350.59%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $307.97
Upside: -26.94%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $5.65
Upside: +289.38%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $16.83
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $5.64
Upside: +431.91%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $5.53
Upside: +62.75%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $5.05
Upside: -40.59%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.35
Upside: +38.09%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $56.35
Upside: -23.69%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $4.42
Upside: -54.75%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $14.75
Upside: +577.97%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $8.69
Upside: +6,804.49%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $93.23
Upside: -46.37%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $36.25
Upside: +24.14%